Global Life Science, Health & Wellness Technology Opportunity Engine 2021: Focus on Gene Therapies, Cancer, Disease Treatment & Monitoring, Surgical Applications and Cosmetics

Dublin, IRELAND


Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Gene Therapies, Cancer, Disease Treatment & Monitoring, Surgical Applications and Cosmetics" report has been added to ResearchAndMarkets.com's offering.

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) consists of insights across gene therapies, cancer, neurological, allergic and respiratory diseases treatment and monitoring. Further, novel drugs, drug delivery systems, surgical support applications, artificial intelligence-based imaging, as well as telehealth systems are discussed. Some innovations cover the upcoming innovations in cosmetics, acne treatment, food packing, and natural extract processing technologies

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Innovations in Life Sciences, Health & Wellness

  • Renovorx, US
  • Hoth Therapeutics, US
  • Swedish Orphan Biovitrum Ab, Sweden
  • Tyto Care, US
  • Scopus Biopharma Inc., US
  • Biolinerx, Israel
  • Innodem Neurosciences, Canada
  • Children's Hospital of Philadelphia & University of Pennsylvania, US
  • Neurent Medical, Ireland
  • Immunocore, UK
  • MIVI Neuroscience, US
  • Bioclinica, US
  • Belite Bio Inc., Ca, US
  • Plus Therapeutics Inc., US
  • Biocryst Pharmaceuticals Inc., US
  • Verrica Pharmaceuticals Inc., US
  • Lygenesis, US
  • Sebela Pharmaceuticals, US
  • Helix, US
  • VOR Biopharma, UK
  • Sustainable Adhesive ProductsT Ltd., Netherlands
  • Mussel Polymers Inc., US
  • Bio-Botanica Inc., US
  • Lachemi Chemorgs, India
  • Locate Bio Limited, UK
  • Viiv Healthcare, US

For more information about this report visit https://www.researchandmarkets.com/r/miha0f

 

Contact Data